Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioceres Crop Solutions (BIOX) EBITDA (2016 - 2026)

Bioceres Crop Solutions' EBITDA history spans 5 years, with the latest figure at -$9.7 million for Q1 2026.

  • On a quarterly basis, EBITDA fell 304.17% to -$9.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$22.7 million, a 111.82% decrease, with the full-year FY2025 number at $3.8 million, down 92.73% from a year prior.
  • EBITDA hit -$9.7 million in Q1 2026 for Bioceres Crop Solutions, down from -$2.4 million in the prior quarter.
  • Over the last five years, EBITDA for BIOX hit a ceiling of -$2.4 million in Q1 2025 and a floor of -$9.7 million in Q1 2026.
  • Historically, EBITDA has averaged -$6.8 million across 3 years, with a median of -$8.2 million in 2022.
  • Biggest five-year swings in EBITDA: tumbled 248.68% in 2022 and later tumbled 304.17% in 2026.
  • Tracing BIOX's EBITDA over 3 years: stood at -$8.2 million in 2022, then surged by 70.79% to -$2.4 million in 2025, then crashed by 304.17% to -$9.7 million in 2026.
  • Business Quant data shows EBITDA for BIOX at -$9.7 million in Q1 2026, -$2.4 million in Q1 2025, and -$8.2 million in Q2 2022.